Picumast

CAS No. 39577-19-0

Picumast( —— )

Catalog No. M36215 CAS No. 39577-19-0

Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 409 In Stock
10MG 604 In Stock
25MG 938 In Stock
50MG 1265 In Stock
100MG 1702 In Stock
200MG Get Quote In Stock
500MG 3422 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Picumast
  • Note
    Research use only, not for human use.
  • Brief Description
    Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.
  • Description
    Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39577-19-0
  • Formula Weight
    440.96
  • Molecular Formula
    C25H29ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=2C(=CC(OCCCN3CCN(CC4=CC=C(Cl)C=C4)CC3)=CC2)OC(=O)C1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Atractylenolide I

    Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.

  • Compound K

    HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.

  • Bisphenol A

    Bisphenol A is a starting material for the synthesis of plastics primarily certain polycarbonates and epoxy resins as well as some polysulfones and certain niche materials. It exhibits estrogen-mimicking hormone-like properties.